Earnings Feed
Start Free
Eton Pharmaceuticals, Inc.·4

Jan 6, 4:22 PM ET

RIEDEL NORBERT G 4

4 · Eton Pharmaceuticals, Inc. · Filed Jan 6, 2025

Insider Transaction Report

Form 4
Period: 2025-01-03
Eton Pharmaceuticals, Inc.ETON
RIEDEL NORBERT G
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2025-01-03$3.58/sh+27,400$98,092→ 87,145 total
  • Exercise/Conversion

    Common Stock

    2025-01-03$3.78/sh+50,000$189,000→ 137,145 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2025-01-03−27,400→ 0 total
    Exercise: $3.58From: 2021-03-12Exp: 2030-03-12→ Common Stock (27,400 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2025-01-03−50,000→ 0 total
    Exercise: $3.78From: 2023-02-07Exp: 2032-02-06→ Common Stock (50,000 underlying)
  • Exercise/Conversion

    Common Stock

    2025-01-03$3.47/sh+25,000$86,750→ 162,145 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2025-01-03−25,000→ 0 total
    Exercise: $3.47From: 2024-02-20Exp: 2033-02-19→ Common Stock (25,000 underlying)

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4 - NR 01.06.25 2